- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
PhRMA Perspectives on Drug Substance Regulatory Filing Issues
Michael Mitchell
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2003, Volume 27, Issue 2
The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.